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Background: Disturbances in blood-brain barrier (BBB) integrity contribute to onset and 
progression of neurodegenerative diseases including Alzheimer’s disease (AD) and vascular 
dementia (VaD). Aging is positively associated with AD and VaD risk, but this may reflect co-
morbidities or the effects of other chronic modulators of vascular function such as diet. To 
explore putative synergistic effects of aging with diet, in this study genetically unmanipulated 
mice were maintained on diets enriched in saturated fatty acids (SFA) or cholesterol and 
compared to mice provided with low-fat feed formula. 
Methods: The functional integrity of the BBB was assessed following 3, 6 and 12months of 
dietary intervention commenced at 6 weeks of age, by determining the brain parenchymal 
extravasation of immunoglobulin-G (IgG). 
Results: Mice maintained on the SFA or cholesterol enriched diet showed significant 
parenchymal IgG abundance following 3 months of feeding, concomitant with diminished 
expression of the tight junction protein occludin. Low-fat control mice had essentially no 
evidence of BBB disturbances. Six months of SFA feeding exacerbated the difference in IgG 
abundance compared to the low-fat fed mice. At 12 months of feeding, the control low-fat fed 
mice also had significant parenchymal IgG that was comparable to mice fed the SFA or 
cholesterol enriched diets for 3 months. However, there may have been an adaptation to the 
fat enriched diets because SFA and cholesterol did not exacerbate IgG parenchymal 
accumulation beyond six months of feeding. 
Conclusion: Collectively, the study suggests that diets enriched in SFA or cholesterol 
accelerate the onset of BBB dysfunction that otherwise occurs with aging. 
Keywords: aging, blood-brain barrier, cholesterol, neurodegenerative disorder, 




Blood-brain barrier (BBB) is a fully differentiated neurovascular endothelial structure in the 
brain. The BBB consists of the tight junctions of vascular endothelial cells overlayed on 
basement membranes and has a critical function excluding plasma-derived neuro-toxic and 
inflammatory agents [1]. Several lines of evidence suggest that chronic disturbances of BBB 
function heighten neuronal inflammation and are likely to contribute to progression of 
neurodegenerative disorders such as Alzheimer’s disease (AD), vascular dementia (VaD), 
multiple sclerosis or Parkinson’s disease [2,3]. Indeed in all these disorders, brain 
parenchymal extravasation of plasma proteins, perivascular gliosis and lacunar lesions are 
commonly reported, observations consistent with breakdown of the BBB [4-6]. 
Risk for several neurodegenerative disorders including AD and VaD are influenced by lifestyle 
choices including nutrition [7-9]. Population and clinical studies show a positive association 
of AD with dietary cholesterol and saturated fatty acids (SFA) [10,11], whereas both mono- 
and poly-unsaturated fatty acids (MUFA and PUFA respectively) appear to confer protection 
for risk of AD [12-14]. One mechanism for the association between dietary fats and AD may be 
via modulation of BBB function. In genetically unmanipulated mice, chronic ingestion of diets 
enriched with SFA or cholesterol, but not in MUFA or PUFA, attenuated the expression of 
endothelial tight junction proteins and resulted in parenchymal extravasation of plasma 
proteins including circulating amyloid-beta [15]. Ghribi et al made similar findings in wild-
type rabbits maintained on cholesterol-supplemented diets and showed amyloid-like plaque 
pathology [16] and in amyloid transgenic mice, SFA/cholesterol enriched diets were shown to 
significantly exacerbate cerebral amyloidosis [17,18]. 
Age is positively associated with the prevalence of dementia [19]. In the United States of 
America, 20% of the population older than 65 years and 50% of the population older than 80 
years have probable AD or VaD. Several mechanisms could notionally explain the ‘age-
induced’ increased risk for dementia phenomenon, but these commonly describe chronically 
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heightened states of systemic inflammation induced by co-morbidities such as diabetes, 
cardiovascular disease and stroke, or because of lifestyle behaviour such as poor nutrition 
and being sedentary [3,8]. In rodent models, otherwise healthy aged mice and rats maintained 
on diets containing just 4% of energy as fat and with little or no SFA/cholesterol nonetheless 
feature BBB abnormalities in comparison to younger aged animals [3,20,21]. The latter 
suggests independent but possibly synergistic effects with other co-morbidities and vascular 
stressors. Accordingly, this study was designed to investigate BBB function in wild-type mice 
that were maintained on either a low-SFA and cholesterol-free diet, or a diet enriched with 
either SFA, or with cholesterol for 3, 6 and 12 months.   
 
2.0 Materials and methods 
2.1 Animals and dietary treatments 
Six-week old, female C57BL/6J mice were purchased from Animal Resources Centre 
(Murdoch, WA, Australia). Mice were held in the accredited animal holding facility (Building 
300, Curtin University) with 12 h light/dark cycle and controlled air temperature and 
pressure. Mice had ad libitum access to the feed and water. 
Groups of 24 mice were randomly allocated to each dietary treatment group. A semi-synthetic 
mice chow diet was provided by Specialty Feeds, (Glenn Forrest, WA, Australia). Control low-
fat diet was the standard rodent chow; AIN93M containing 4% (w/w) of dietary fats as 
polyunsaturated oil and no cholesterol (see table 1 for detail). The cholesterol diet was 
produced by providing 1% (w/w) cholesterol into the AIN93M control chow. An enriched SFA 
diet was prepared by adding 20% (w/w) of SFA derived from cocoa butter. Digestible energy 
from the cocoa butter in SFA diet was 40% and the main fatty acids in the diet were palmitic 
(16:0, 5%), stearic (18:0, 7%) and oleic acid (18:1n-9, 6%) (Table 1). Eight mice from each 
group were sacrificed at 3, 6 and 12 months after the commencement of dietary treatment, 
and the brain and plasma samples were collected for the analysis as described previously [15]. 
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All experimental procedures in this study were approved by a National Health and Medical 
Research Council of Australia accredited Animal Ethics Committee (Curtin University 
approval no: R08-10). 
 
2.2 Quantitative immunofluorescent microscopy of cerebral IgG extravasation 
The integrity of the BBB was determined by the detection of cerebral perivascular 
extravasation of plasma protein, IgG. This is a widely used and established method [22,23] 
and in this study we used published quantitative 3-D immuno-microscopy methods described 
previously [8,9,15,24-26] with minor modifications. The right hemisphere of the brain was 
carefully isolated and washed in ice-cold PBS. The brain tissues were immersion-fixed in 4% 
paraformaldehyde for 24 h and cryoprotected in 20% sucrose for 3 days. The tissues were 
then frozen in isopentane/dry ice and stored at -80C. Brain cryosections of 20µm were 
prepared on polysine coated microscope slides and the unspecific binding sites were blocked 
with 10% goat serum in PBS for 30 min. Goat anti-mouse IgG conjugated with Alexa488 
fluorochrome (Invitrogen, US) was applied to the sections at a concentration of 1:50 in PBS, 
and incubated at 4 C for 20 h. After a thorough wash of the sections with PBS, DAPI counter 
staining (Invitrogen) was done for nuclei detection, and the sections were mounted with anti-
fade mounting medium. 
The immunofluorescent micrographs were taken in 3-D with AxioVert 200M (Carl-Zeiss, 
Germany) coupled with mRM digital camera and ApoTome optical sectioning system. Each 3-
D image was captured at a magnification of x200 (Plan-Neofluar 20x objective lens) and 
consisted of at least twelve 2-D Z-stack images with 1.225 µm axial distance optimized by 
Nyquist theory. For each cortex and hippocampal formation regions 5-12 three-dimensional 
images were randomly taken from each brain section, and all the 3-D images were used for 
the following quantitative analysis. Fluorescent voxel intensity of the IgG perivascular 
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extravasation was calculated with Volocity 3-D image analysis software (PerkinElmer, UK) 
and expressed as per volume unit. 
 
2.3 Immunofluorescent quantitative analysis of the cerebrovascular tight junction protein, 
occludin-1 
The abundance of cerebrovascular tight junction, occludin-1, relative to the endothelium was 
quantitatively determined in the cortex and hippocampus using three-dimensional double 
immunofluorescent microscopy as described previously [15,24]. Briefly, the brain 
cryosections (20 µm thick) were fixed with acetone at -20 C for 3 min and heat-mediated 
antigen retrieval was conducted by incubating the sections in 60 C water for 2 h. Endogenous 
biotin was blocked with avidin in egg white and biotin in skimmed milk. In order to avoid the 
cross-reaction of the two polyclonal antibodies, the concentration of the first antibody was 
diluted so that it was undetectable with conventional secondary antibody detection, but 
detectable after the biotin-avidin signal amplification. The sections were incubated with 
rabbit anti-mouse occludin-1 (1:200, Invitrogen) for 20 h at 4 C after blocking of unspecific 
biding sites with 10% goat serum. The sections were then incubated with anti-rabbit IgG 
conjugated with biotin (1:200, DAKO) for 2 h at 20 C. Rabbit anti-von-Willebrand factor 
(1:200, Abcam) was applied to the sections for 2 h at 20 C. Finally the sections were 
incubated with a mixture of avidin conjugated with Alexa546 and anti-rabbit IgG conjugated 
with Alexa488. The nuclei were counterstained with DAPI. The colocalization of occludin-1 
and vWF was determined, and the optical pixel intensity of the occludin-1 in the colocalized 
area was calculated with AxioVision imaging software. The total vWF expression was also 
determined by calculating the voxel intensity with Volocity. The cerebrovascular expression 
of occludin-1 was expressed as relative to the total vWF expression. 
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2.4 Immunofluorescent analysis of cerebral GFAP and its colocalization with perivascular IgG 
extravasation 
Similar to cerebral IgG immuno-microscopy, the cortex and hippocampus expression of GFAP 
was determined as a surrogate marker for astrocyte activation by utilizing quantitative 
immunofluorescent microscopy. The brain cryosections were blocked with 10% goat serum 
and incubated with rabbit anti-mouse GFAP (1:500, Abcam, UK) for 20 h at 4 C. Goat anti-
rabbit IgG with Alexa546 was then added to the section for 1 h, and the sections were counter 
stained with DAPI.  
The colocalization of activated GFAP with the cerebral perivascular IgG leakage was also 
determined with double immunofluorescent staining. A mixture of goat anti-mouse IgG 
Alexa488 and rabbit anti-mouse GFAP was applied to the sections and incubated for 20 h at 4 
oC. After a thorough wash, anti-rabbit IgG Alexa546 was added to the sections and incubated 
for 1 h. The colocalization of 2 proteins was analyzed by Volocity. 
 
2.5 Determination of plasma S100B 
S100B is a calcium binding protein predominantly produced by astrocytes and abundant in 
cerebrospinal fluid but not in peripheral tissue or plasma [27]. The CSF and/or plasma S100B 
is elevated in a number of neurodegenerative diseases including stroke and schizophrenia 
[28-30]. Therefore the plasma concentration of S100B is often used as a marker of BBB 
integrity and cerebrovascular inflammation [27,31,32]. Plasma S100B was measured by 
ELISA kit (CosmoBio, Japan) as per the instructions provided by the manufacturer. Briefly, 20 
µl of plasma samples, or of the S100B standards (0, 98, 197, 394, 1575, 3150 and 6300 pg/ml) 
were incubated overnight at 4 oC in 96-well microplates coated with the primary antibody. 
Thereafter, plates were incubated with conjugated secondary antibody for 2 hours, followed 
by 2 hours incubation with streptavidin-HRP. Finally samples were incubated with substrate 
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solution for 20 min and the reaction was terminated with stopping solution. The optical 
absorbance was measured at 490 nm. 
 
2.6 Plasma lipid assays 
Plasma total cholesterol and triglycerides were determined with colorimetric assays (Randox, 
UK) according to the manufacturer’s instruction with minor modifications. Briefly, 2 µL of 
sample plasma or standard solution was added to 96-well microplate, and 200 µL of assay 
reagent was added. Samples were incubated for 5 min at 37 oC and the optical absorbance was 
measured at 500nm. For cholesterol assay, standard was plotted at 0, 1.25, 2.5 and 5.0 
mmol/L. For triglycerides assay, standard was plotted at 0, 1.1 and 2.19 mmol/L. 
 
2.7 Statistics 
For the quantitative immuno-microscopy a minimum of 60 two-dimensional images were 
taken from each mouse and in total more than 480 images per group. For IgG extravasation, 
plasma S100B and cerebral GFAP, the cumulative effects through the entire experimental 
period were estimated by analyzing the area under the curve (AUC). The calculation of 
standard deviations for AUC was conducted according to the method of Bailer [33]. One-way 
ANOVA followed by post hoc tests was used to determine the statistical significance (p<0.05, 
SPSS). For plasma lipid assays, the Pearson’s correlation coefficient of plasma lipid level and 




The effect of aging and potential synergistic effects with diets enriched in either SFA or 
cholesterol on parenchymal extravasation of IgG is demonstrated in figure 1 and 
quantitatively compared in figure 2 for different durations of feeding. After 3 months of 
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dietary intervention, there was limited IgG abundance within brain parenchyme in mice 
maintained on the LF-control diet. However, in LF-fed mice there was a four- and nine-fold 
increase in plasma derived IgG after 6 and 12 months of dietary intervention respectively (Fig 
2A).  
We confirm that mice maintained on a diet supplemented with cholesterol, or enriched with 
SFA for 3 months had substantially greater parenchymal IgG abundance than control mice on 
the LF-diet (Fig 2A). However, interactive effects with age became evident particularly in mice 
maintained on the SFA enriched diet. Expressed as the cumulative index of IgG abundance (ie 
area under the curve between 3 and 12 months of feeding; CIGAUC), mice maintained on SFA 
had a 3-fold greater rate of IgG accumulation than the LF-control group (Fig 2B). Cholesterol 
supplemented mice like the SFA fed mice had an earlier onset of parenchymal accumulation of 
IgG compared to LF-controls with significant divergence between the two groups at 3 months. 
However, after 12 months of dietary intervention, the two groups showed similar levels of 
parenchymal IgG abundance. Indeed, there was no difference in CIGAUC up to 12 months of 
feeding for the cholesterol-supplemented versus LF-control mice (Fig 2B).  
Considering brain-to-blood leakage of S100B mirrored the significant differential effects of 
aging and dietary SFA/cholesterol on BBB integrity. Mice maintained on the LF-diet showed a 
remarkable increase in plasma S100B after 12 months of dietary intervention compared to 3 
months (Fig 3A). Similarly, the SFA or dietary cholesterol supplemented mice had marked 
elevations in plasma S100B at 3 months of feeding.  The cumulative plasma index of S100B 
(CIS100BAUC) was significantly increased in the SFA fed mice (Fig 3B), but there was no 
difference between cholesterol fed mice and LF-controls.  Concomitant with increased plasma 
S100B and parenchymal abundance of IgG, was a significant reduction in the endothelium 
abundance of the tight junction occludin-1 (Fig 4).  
To explore if disturbances in BBB function induced by aging and accelerated onset by dietary 
SFA or cholesterol was associated with cerebrovascular inflammation, determining the 
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abundance of GFAP and its putative colocalization with parenchymal IgG accumulation 
assessed the activation of cerebral astroglial cells. Figure 5 shows the exaggerated abundance 
of GFAP and significant co-localisation with IgG in LF-control mice after 12 months of dietary 
intervention. The GFAP/IgG association was also evident in the SFA fed mice and cholesterol 
fed mice (not illustrated). Consistently, the Pearson’s correlation coefficient analysis showed a 
significant correlation (p<0.0001) between the cerebral GFAP expression and IgG association 
in all groups (Fig 6C). The expression of GFAP in the cortex was greater in SFA and cholesterol 
supplemented mice after 3 months of dietary intervention but there was no significant 
difference between the groups at 12 months (Fig 6A). An accelerated inflammatory onset 
associated with SFA feeding is suggested by the cumulative index of cortex GFAP (CIGFAPAUC) 
which was greater in the SFA fed mice compared to LF control. 
Plasma lipids were determined to explore if there was an association with the parenchymal 
appearance of IgG in aged and SFA/cholesterol supplemented mice. The diets given to mice 
were well tolerated and similar rates of weight gain were observed in all groups of mice (data 
not shown). The SFA fed mice were hypertriglyceridemic at 3 months of feeding compared to 
LF-control mice, but there was no difference by 12 months of intervention between the 
groups of mice (Fig 7C). Whereas mice maintained on cholesterol became 
hypercholesterolemic and the divergence compared to the LF-control group increased with 
age (Fig 7A). Correlation analysis found no association of plasma triglyceride concentration 
and cerebral IgG extravasation (Fig 7D). In contrast, there was a modest but nonetheless 
statistically significant association between plasma cholesterol and parenchymal IgG (Fig 7B). 
 
4.0 Discussion 
An accumulating body of evidence suggests that the dysfunction of BBB followed by blood-to-
brain leakage of plasma neuro-inflammatory substances may be important to the onset and 
progression of neurodegenerative disorders including AD and VaD. Some studies suggest that 
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the disruption of BBB occurs with normal aging, however this hypothesis may be confounded 
because of co-morbidities that develop with age, or because of persistent poor lifestyle 
choices including dietary behaviour.  To explore the concept of an age-induced effect on BBB 
function and synergistic effects with dietary fats, in this study, a wild-type mouse model was 
used to examine whether BBB disruption develops in aging mice maintained on a low-fat and 
cholesterol free diet and whether this is influenced by diets enriched in SFA or cholesterol.  
The blood-to-brain leakage of plasma protein, IgG (150 kDa), is a commonly used approach to 
assess BBB integrity and function [16,22,23]. In this study we used an established highly 
sensitive immunofluorescent microscopy procedure to quantitatively assess the parenchymal 
abundance of IgG [15,24]. In addition, colocalisation analysis with specific markers of 
cerebrovascular inflammation (GFAP) were determined in three-dimensions.  
Consistent with previous studies [15], we confirm the significant parenchymal abundance of 
IgG in mice maintained on SFA, or a cholesterol-rich diet for 3 months. However, there was no 
evidence that this occurred in mice maintained on a low-fat and cholesterol-free diet for 3 
months. Accumulation of parenchymal IgG occurred concomitant with  a significant reduction 
in the endothelial tight junction protein occludin-1 consistent with disturbed BBB function. 
We extend on those findings and now demonstrate that parenchymal extravasation of IgG 
progressively increases in aging mice maintained in what is considered a balanced LF-diet. 
Indeed, there was a strong association of IgG extravasation and age, with substantially greater 
IgG after 12 months of dietary intervention, compared to 6 months. Confirmation of an age-
induced effect was also supported by findings of the plasma concentration of the neuronal 
peptide S100B. Mice maintained on the LF diet had significantly greater plasma S100B after 
12 months of dietary intervention > 6 months compared to 3 months. Collectively, the data 
suggests that BBB function becomes progressively compromised with age, resulting in 
bidirectional and probably non-specific trafficking of proteins that are normally otherwise 
excluded. Given that the average life span of genetically unmanipulated laboratory mice is 18 
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to 20 months, the findings suggest that the phenomenon of plasma derived protein 
extravasation commences at approximately ‘middle-age’.  
Concomitant with parenchymal IgG extravasation in LF-control mice was evidence of 
cerebrovascular-specific inflammation equivocally demonstrated by increased expression of 
GFAP after 6 and 12 months of dietary intervention. Moreover, there was significant 
colocalisation of glial cell activation (indicated by GFAP) with IgG parenchymal penetration, 
consistent with a causal effect. 
Up to 6-months of dietary intervention, the data indicates that there may have been 
synergistic effect of SFA with age, because divergence in the rate of IgG extravasation was 
observed between the two groups of mice (ie: difference between two groups continued to 
increase between 3 and 6 months of dietary intervention). However, beyond 6 months, SFA 
feeding did not appear to exacerbate BBB dysfunction compared to the effects of aging alone. 
The earlier onset and accelerated-induction response because of SFA feeding is supported by 
the finding of a substantially greater CIGAUC in the SFA group compared to LF-aged mice. 
However, we cannot determine from this study, whether introduction of SFA in perhaps 
already aged mice with established BBB dysfunction will have an additive effect on 
deterioration.  
Mice maintained on a diet containing an additional 1% of cholesterol by weight like the SFA-
fed mice had accelerated onset of IgG accumulation within brain parenchyme compared to LF-
fed mice. However, the differential effect induced by dietary cholesterol was no longer evident 
after 6 or 12 months of intervention. Following 6 months of feeding, the IgG extravasation was 
not significantly different to the LF-control group and neither was there any difference in the 
CIGAUC or the CIS100BAUC. 
Collectively, given that neither dietary SFA nor cholesterol continues to exacerbate 
parenchymal extravasation of IgG beyond 6 months of intervention suggests either an 
adaptation response to the fat enriched diets, or perhaps a sub-maximal effect. The former is 
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more likely given the persistent difference between the 12 months SFA-feeding, versus either 
the cholesterol-fed or LF-control groups of mice.  
Several mechanisms could explain the accelerated onset phenomenon observed in SFA and 
cholesterol supplemented mice, however the reason for IgG extravasation in LF-control mice 
at older age is less obvious. Lipotoxicity is a term used for a process that leads to an end-organ 
damage caused by excessive cellular lipid overload. Morgan suggests that the underlying 
toxicity of SFA is a consequence of disturbances in protein processing and endoplasmic 
reticulum (ER) dysfunction, for example apoptotic induction [34]. One relevant example was a 
study by Patil et al. who found that dietary palmitic acid induced region-specific cerebral 
damage because of higher fatty acid-metabolizing capacity of cortical astroglia [35]. 
Conversely, cell culture studies suggest that incubation with longer chain unsaturates has an 
antagonistic effect on stress pathways [36]. Similarly Yao and colleagues suggest that excess 
cholesterol causes ER and mitochondrial stress that can lead to apoptosis [37]. Mitochondrial 
activity or lysosomal processing can result in the production of oxidized lipids including 
cholesterol. A number of studies support the contention that oxidized lipids compromise 
tissue integrity and exacerbate inflammatory pathways [38,39]. However, if mitochondrial 
and ER stress are central to the effects of SFA and cholesterol, it is unclear how the effects 
would become mitigated with increased duration of feeding.   
The data in this study showed a significant increase in plasma cholesterol in cholesterol fed 
mice, but there was only a weak positive association with BBB dysfunction. The SFA 
supplemented mice showed no changes in plasma cholesterol and triglyceride. Hence, we 
cannot completely rule out an effect of dyslipidemia. 
Alternative explanations for BBB dysfunction with aging that is independent of co-morbidities 
or other obvious lifestyle related are relatively few. Repetitive hypoxic episodes were 
proposed to compromise capillary integrity either directly, or because of diminished VEGF 
mediated angiogenesis following hypoxic episodes (which tend to increase with age) [40-44]. 
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Alternatively, what we ordinarily consider to be complete, balanced or otherwise healthy 
diets may in a chronic context be subtly inadequate or deficient. Another explanation is that 
transient episodes of inflammation in response to infection or injury, transient metabolic 
disturbances, or acute ingestion of pro-inflammatory compounds may provide repeated 
insults that are physiologically important, but difficult to monitor [4]. In this study, mice were 
closely assessed for infection or disease utilizing sentinel mice maintained within the same 
facility, but we did not identify any periods of infection with micro-organisms. On the other 
hand, the diet was not altered for the duration of the study and so nutrient insufficiency, or 
other dietary pro-inflammatory components cannot be ruled out. Finally, only modest 
environmental enrichment was provided (limited to ‘hide boxes’), which may have resulted in 
stress related effects.  
In conclusion, this study for the first time quantitatively demonstrated a progressive decline 
in BBB function as a consequence of aging in genetically unmanipulated mice maintained on a 
low-fat and cholesterol free diet. Early introduction of diets enriched in SFA or cholesterol 
were found to accelerate the onset of BBB dysfunction that occurs with aging. Dietary SFA, but 
not cholesterol had a synergistic effect with aging on the degree of BBB dysfunction over the 
first six months of feeding, that persisted in mice after 12 months of dietary intervention. 
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6.0 Figure Legends 
Table 1. Detailed dietary composition of mouse chow. The table shows the detailed lipid 
composition in the diets used in this study. Control diet was AIN93M standard low-fat rodent 
chow containing no cholesterol and 4% unsaturated fats. The cholesterol diet contained 1% 
(w/w) of sterol. Saturated fat (SFA) diet contained 20% (w/w) saturated fats from cocoa 
butter.  
 
Figure 1. 3-D immunofluorescent microscopy of cerebral IgG extravasation. The 
integrity of the BBB was assessed by the cerebral extravasation of plasma protein, IgG. The 
immunofluorescent micrographs show the distribution of IgG in the brain (green) of low-fat 
control, high-cholesterol or high-saturated fat (SFA) fed mice following 3 months and 12 
months of dietary intervention. DAPI counterstaining was used to stain the nuclei (blue). The 
upper frames show the 2-D extended focus micrographs of 3-D images taken at a 
magnification of x200 (scale bar=100 µm). The lower frames are the magnified 3-D 
micrographs of the indicated area of the white rectangle in the 2-D images; with dimensions 
of 206 µm (X axis), 154 µm (Y axis) and 12.25 µm (Z axis).  
 
Figure 2. 3-D semi-quantitative analysis of blood-brain barrier integrity. As a marker of 
blood-brain barrier dysfunction, cerebral IgG extravasation was quantitatively determined in 
3-D in animals maintained on diets with low-fat control, saturated fat (SFA) enriched or  
cholesterol supplemented diets. (A) Voxel intensity of perivascular fluorescent IgG staining in 
the image was measured per volume unit. Data are shown as mean±SEM. Data significantly 
differ from control (Dietary effects) is indicated by * (n=8, p<0.05, one-way ANOVA), and 
significance within each group (Aging/Duration effects) is indicated by alphabetical letters 
(n=8, p<0.05, one-way ANOVA). (B) In addition, the total cumulative IgG extravasation during 
the entire dietary intervention period was estimated by calculating the area under the curve 
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(AUC±SD). Statistical significance is indicated with alphabetical letters (n=8, p<0.05, one-way 
ANOVA). 
 
Figure 3. Plasma marker of blood-brain barrier integrity. (A) The plasma concentration 
of S100B was measured with ELISA kits as a surrogate marker for blood-brain barrier 
dysfunction in mice maintained on a cholesterol-free low-fat diet, or a diet enriched in 
saturated fat diet (SFA) or cholesterol. Data are shown as mean±SEM. Data significantly differ 
from control (Dietary effects) are indicated by * (n=8, p<0.05, one-way ANOVA), and 
significance within each group (Aging/Duration effects) is indicated by alphabetical letters 
(n=8, p<0.05, one-way ANOVA). (B) The total cumulative plasma S100B concentrations were 
estimated with area under the curve (AUC±SD). Statistical significance is indicated with 
alphabetical letters (n=8, p<0.05, one-way ANOVA). 
 
Figure 4. Double immunostaining of occludin-1 and von-Willebrand factor. (A) The 3-D 
immuno-micrographs show the cerebral abundance of occludin-1 (shown in yellow) and von-
Willebrand factor (vWF, shown in magenta) in the brains of the mice maintained on control 
low-fat chow, diet enriched in cholesterol or saturated fat (SFA) for 3 months. The dimensions 
of the micrographs are 138 µm (X axis), 98 µm (Y axis), and 12.5 µm (Z axis). (B) The total 
expression of cerebrovascular endothelium was quantitatively measured by estimating the 
voxel intensity of the fluorescent staining of von-Willebrand factor (vWF). The abundance of 
cerebrovascular occludin-1 was measured in the area where vWF and occludin-1 are 
colocalized, and express as relative to the vWF expression. Data are shown as mean±SEM. 
Statistical significance was indicated with alphabetical letters (n=8, p<0.05, one-way ANOVA). 
 
Figure 5. Colocalization of cerebral IgG extravasation and astrocyte activation. The 
immunofluorescent images show the double immunolabelling of cerebral IgG and GFAP in the 
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cortex. Cerebrovasculature with significant cerebral IgG leakage induced by aging in 12 
months low-fat fed mice were accompanied with substantial GFAP activation (red) whereas 
vessels with no IgG extravasation in 3 months low-fat fed mice showed no surrounding 
activated GFAP. The nuclei were counterstained with DAPI (blue). The images were taken at a 
magnification of x200 and the 3-D dimensions were 430 µm (X axis), 322 µm (Y axis) and 15 
µm (Z axis). 
 
Figure 6. 3-D semi-quantitative analysis of cerebral astrocyte activation. The activation 
of astrocytes in the cortex was semi-quantitatively analysed in mice maintained a low-fat diet, 
or a diet enriched in saturated fat diet (SFA) or cholesterol. (A) Voxel intensity of 
immunostained GFAP was measured per volume unit and express as mean±SEM. Data 
significantly differ from control (Dietary effects) are indicated by * (n=8, p<0.05, one-way 
ANOVA), and significance within each group (Aging/Duration effects) is indicated by 
alphabetical letters (n=8, p<0.05, one-way ANOVA). (B) The total cumulative activation index 
of astrocyte during the entire dietary intervention period was also estimated with area under 
the curve (AUC±SD). Statistical significance is indicated with alphabetical letters (n=8, p<0.05, 
one-way ANOVA). (C) Pearson’s correlation between the cerebral IgG extravasation and GFAP 
expression was analysed. 
 
Figure 7. Plasma lipid analysis. (A) The concentration of plasma total cholesterol and 
triglyceride were determined colorimetric assays in control low-fat fed mice and animals 
maintained on diets enriched in saturated fat (SFA) or choelsterol. (B) The correlation of 
plasma lipids versus blood-brain barrier dysfunction (IgG extravasation) was determined. (C) 
The data are shown as mean±SEM. Data significantly differ from control (Dietary effects) are 
indicated by * (n=8, p<0.05, one-way ANOVA), and significance within each group 






  Control Cholesterol SFA 
Total Fat 4% 5% 20.3% 
% total digestible energy 
from lipids 
n/a n/a 40% 
Cholesterol not detected 1.00% not detected 
SFA C12:0 and less n/a n/a n/a 
Myristic Acid 14:0 trace trace 0.05% 
Pentadecanoic Acid 15:0 n/a n/a 0.01% 
Palmitic Acid 16:0 0.20% 0.20% 5.16% 
Magaric Acid 17:0 n/a n/a 0.05% 
Stearic Acid 18:0 0.10% 0.10% 7.31% 
Arachidic Acid 20:0 n/a n/a 0.24% 
Behenic Acid 22:0 n/a n/a 0.04% 
Tetracosanoic Acid 24:0 n/a n/a 0.03% 
Palmitoleic Acid 16:1 trace trace 0.05% 
Heptadecenoic Acid 17:1 n/a n/a 0.01% 
Olecic Acid 18:1 n9 2.40% 2.40% 6.62% 
Gadoleic Acid 20:1 trace trace 0.01% 
Linoleic Acid 18:2 n6 0.80% 0.80% 0.67% 
Linoleic Acid 18:3 n3 n/a n/a 0.05% 
Linoleic Acid 18:3 n6 0.40% 0.40% not detected 
Stearidonic Acid 18:4 n3 n/a n/a n/a 
Arachadonic Acid 20:4 n6 trace trace not detected 
EPA 20:5 n3 trace trace not detected 
DPA 22:5 n3 n/a n/a not detected 
DHA 22:6 n3 trace trace not detected 
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